Hong Kong: IPO SPOTLIGHT - OVERVIEW 2025
Hong Kong is the top global destination for IPOs in 2025, with over HK $280 billion raised so far. Large scale A+H dual listings have surged this...
961 Views
Pre-IPO CF PharmTech (PHIP Updates) - Some Points Worth the Attention
CF PharmTech's core driver CF017 faces challenges from policy adjustments/competition. Slowdown in revenue growth and heavy reliance on single...
992 Views
Pre-IPO CF PharmTech - The Outlook Is Bleak Due to VBP and Fierce Competition
CF PharmTech focus on generic drugs, facing fierce competition and struggling to generate profits due to high single product risk and VBP. Pre-IPO...
709 Views